Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Response Relationship, Drug”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00776425
What this trial is testing

The Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 117
Early research (Phase 1)Study completedNCT00000721
What this trial is testing

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Early research (Phase 1)Study completedNCT00000849
What this trial is testing

Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT00006075
What this trial is testing

Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT04550832
What this trial is testing

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

Who this might be right for
Infections and InfestationsPulmonary Tuberculosis
LigaChem Biosciences, Inc. 76
Early research (Phase 1)Study completedNCT00028418
What this trial is testing

Clofarabine in Chronic Lymphocytic Leukemia

Who this might be right for
Hematologic NeoplasmsLymphoproliferative DisordersLeukemia+1 more
M.D. Anderson Cancer Center 100
Large-scale testing (Phase 3)Looking for participantsNCT06740214
What this trial is testing

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty

Who this might be right for
Pain, PostoperativeAnalgesic EffectTotal Knee Arthroplasty+2 more
The University of Hong Kong 177
Not applicableStudy completedNCT00000377
What this trial is testing

Preventing the Return of Depression in Elderly Patients

Who this might be right for
Depression
University of Pittsburgh
Early research (Phase 1)Study completedNCT00006207
What this trial is testing

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)UnknownNCT02323282
What this trial is testing

The Study of Ropivacaine Median Effective Concentration in Ultrasound-guided Supraclavicular Brachial Plexus Block

Who this might be right for
Anesthesia
Yu Shan 60
Early research (Phase 1)Study completedNCT00001113
What this trial is testing

AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00000952
What this trial is testing

Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00000857
What this trial is testing

Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Early research (Phase 1)Study completedNCT00000906
What this trial is testing

Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Study completedNCT00000704
What this trial is testing

Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Study completedNCT00000948
What this trial is testing

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT00006279
What this trial is testing

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Next Page